7Baggers

Tango Therapeutics Inc
(NASDAQ:TNGX) 

TNGX stock logo

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine pho...

Founded: 2017
Founder: Barbara Weber, Alan Ashworth, William Kaelin Jr, Antoni Ribas, José Baselga, and Timothy Lu 
CEO: Barbara Weber  
Sector: REAL ESTATE & CONSTRUCTION
Industry: BLANK CHECKS
HealthcareSPAC
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 
                        
      collaboration revenue
    		  53,811,000 3,181,000 5,392,000 4,117,000 11,607,000 7,775,000 6,471,000 5,431,000 10,732,000 9,598,000 5,766,000 6,411,000 6,920,000 5,771,000 5,758,000 5,716,000 6,787,000  
      operating expenses:
    		                    
      research and development
    		33,534,000 32,101,000 30,815,000 32,807,000 36,442,000 33,937,000 33,263,000 38,654,000 38,065,000 31,339,000 27,149,000 28,671,000 28,039,000 29,091,000 28,744,000 23,741,000 24,330,000 21,634,000 21,923,000  
      general and administrative
    		15,235,000 9,763,000 8,924,000 11,341,000 11,480,000 11,090,000 11,222,000 10,773,000 10,661,000 9,105,000 9,209,000 9,174,000 8,013,000 7,887,000 8,099,000 7,232,000 6,807,000 6,066,000 4,433,000  
      total operating expenses
    		48,769,000 41,864,000 39,739,000 44,148,000 47,922,000 45,027,000 44,485,000 49,427,000 48,726,000 40,444,000 36,358,000 37,845,000 36,052,000 36,978,000 36,843,000 30,973,000 31,137,000 27,700,000 26,356,000  
      income from operations
    		-48,769,000   -40,967,000 -42,530,000 -40,910,000 -32,878,000 -29,552,000 -42,255,000 -35,013,000 -25,626,000 -23,247,000 -30,286,000 -30,567,000 -29,923,000 -25,202,000 -25,379,000 -21,984,000 -19,569,000 -770,235 
      yoy
    		14.67%   38.63% 0.65% 16.84% 28.30% 27.12% 39.52% 14.55% -14.36% -7.76% 19.33% 39.04% 52.91% 3171.99%     
      qoq
    		   -3.68% 3.96% 24.43% 11.25% -30.06% 20.68% 36.63% 10.23% -23.24% -0.92% 2.15% 18.73% -0.70% 15.44% 12.34% 2440.65%  
      operating margin %
    		-Infinity% NaN% 0% -1287.87% -Infinity% -993.68% -283.26% -148.69% -Infinity% -644.69% -238.78% -159.25% -Infinity% -476.79% -432.41% -436.70% -Infinity% -384.60% -288.33% -Infinity% 
      other income:
    		                    
      interest income
    		2,177,000 1,680,000 1,097,000 1,239,000 1,614,000 1,813,000 1,809,000 2,071,000 2,197,000 2,236,000 1,872,000 1,450,000 1,061,000 591,000 350,000 297,000 218,000 196,000 91,000  
      other income
    		1,079,000 1,380,000 705,000 910,000 1,074,000 1,476,000 1,956,000 1,995,000 2,184,000 2,061,000 1,514,000 1,151,000 1,217,000 967,000 523,000 50,000  -81,000 -50,000  
      total other income
    		3,256,000 3,060,000 1,802,000 2,149,000 2,688,000 3,289,000 3,765,000 4,066,000 4,381,000 4,297,000 3,386,000 2,601,000 2,278,000 1,558,000 873,000 347,000 171,000 115,000 41,000  
      income before income taxes
    		-45,513,000   -38,818,000 -39,842,000 -37,621,000 -29,113,000 -25,486,000 -37,874,000 -30,716,000 -22,240,000 -20,646,000  -29,009,000 -29,050,000 -24,855,000 -25,208,000 -21,869,000 -19,528,000  
      provision for income taxes
    		-1,000   -35,000 -34,000 -49,000 -54,000 -65,000 -40,000 -47,000 -23,000 -64,000  -51,000    -177,000 -62,000  
      net income
    		-45,514,000 -38,749,000 15,884,000 -38,853,000 -39,876,000 -37,670,000 -29,167,000 -25,551,000 -37,914,000 -30,763,000 -22,263,000 -20,710,000 -28,008,000 -29,060,000 -29,050,000 -24,858,000 -25,208,000 -22,046,000 -19,590,000 -764,601 
      yoy
    		14.14% 2.86% -154.46% 52.06% 5.17% 22.45% 31.01% 23.38% 35.37% 5.86% -23.36% -16.69% 11.11% 31.82% 48.29% 3151.11%     
      qoq
    		17.46% -343.95% -140.88% -2.57% 5.86% 29.15% 14.15% -32.61% 23.25% 38.18% 7.50% -26.06% -3.62% 0.03% 16.86% -1.39% 14.34% 12.54% 2462.12%  
      net income margin %
    		-Infinity% -Infinity% 29.52% -1221.41% -Infinity% -914.99% -251.29% -128.56% -Infinity% -566.43% -207.45% -141.87% -Infinity% -453.28% -419.80% -430.74% -Infinity% -385.69% -288.64% -Infinity% 
      net loss per common share – basic and diluted
    		-320   -350 -360 -340 -270 -240 -350 -300 -230 -230 -320 -330 -330 -280 -290 -260 -280  
      weighted-average number of common shares outstanding – basic and diluted
    		143,576,292,000 116,166,187,000  110,540,836,000 110,301,256,000 109,226,731,000 108,507,390,000 108,314,279,000 108,171,463,000 94,572,448,000 97,033,273,000 88,354,590,000 88,193,917,000 87,820,037,000 87,892,195,000 87,839,804,000 87,670,653,000 62,108,032,000 70,160,663,000  
      other comprehensive income:
    		                    
      unrealized gain on marketable securities
    		-339,000 103,000 27,000   -414,000 1,084,000 -77,000 -443,000 867,000 836,000 684,000 1,504,000    -2,645,000 -755,000 -12,000  
      comprehensive loss
    		-45,853,000   -38,953,000 -40,018,000 -38,084,000 -28,083,000 -25,628,000 -38,357,000 -29,896,000 -21,427,000 -20,026,000 -26,504,000 -27,909,000 -29,559,000 -25,795,000 -27,853,000 -22,801,000 -19,602,000  
      license revenue
    		       12,100,000    5,000,000         
      total revenue
    		  53,811,000 3,181,000  4,117,000 11,607,000 19,875,000  5,431,000 10,732,000 14,598,000  6,411,000 6,920,000 5,771,000  5,716,000 6,787,000  
      yoy
    		  363.61% -83.99%  -24.19% 8.15% 36.15%  -15.29% 55.09% 152.95%  12.16% 1.96%      
      qoq
    		  1591.64%   -64.53% -41.60%   -49.39% -26.48%   -7.36% 19.91%   -15.78%   
      operating income
    		 -17,356,250 14,072,000                  
      pretax income
    		 -15,696,500 15,874,000                  
      benefit from income taxes
    		 -14,750 10,000             -3,000     
      net income per common share – basic
    		 -142.5 140                  
      weighted-average number of common shares outstanding – basic
    		  110,966,345,000                  
      net income per common share – diluted
    		 -142.5 130                  
      weighted-average number of common shares outstanding – diluted
    		  117,782,074,000                  
      comprehensive income
    		 -15,765,000 15,911,000                  
      unrealized loss on marketable securities
    		   -100,000 -142,000         1,151,000 -509,000 -937,000     
      other comprehensive loss:
    		                    
      other expense
    		                -47,000    
      general and administrative expenses
    		                   712,913 
      administrative expenses - related party
    		                   30,000 
      franchise tax expense
    		                   27,322 
      interest earned on investments held in trust account
    		                   5,634 
      loss before income tax expense
    		                   -764,601 
      income tax expense
    		                    
      weighted-average shares outstanding, of public shares
    		                   16,675,000 
      basic and diluted net income per share, public shares
    		                    
      weighted-average shares outstanding, of founder shares
    		                   4,702,250 
      basic and diluted net loss per share, founder shares
    		                   -0.16 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                           
        assets
      		                     
        current assets:
      		                     
        cash and cash equivalents
      		157,828,000 112,279,000 58,338,000 39,272,000 58,432,000 69,530,000 53,148,000 51,566,000 61,163,000 66,385,000 58,533,000 66,052,000 57,252,000 59,968,000 100,312,000 104,582,000 99,909,000 142,745,000 204,974,000   
        marketable securities
      		222,011,000 230,859,000 94,473,000 141,513,000 158,292,000 188,387,000 240,130,000 270,545,000 282,436,000 270,500,000 301,347,000 244,600,000 276,387,000 306,165,000 292,981,000 311,774,000 349,976,000 342,510,000 298,831,000   
        restricted cash
      		 428,000 428,000 428,000 428,000     856,000 856,000 856,000  567,000 567,000 567,000 567,000 567,000 2,279,000   
        prepaid expenses and other current assets
      		12,488,000 10,190,000 10,540,000 8,887,000 7,778,000 8,426,000 7,537,000 6,299,000 8,437,000 8,797,000 10,155,000 9,035,000 9,361,000 6,572,000 5,814,000 17,162,000 8,202,000 4,516,000 4,534,000   
        total current assets
      		392,327,000 353,756,000 163,779,000 190,100,000 224,930,000 266,343,000 300,815,000 328,410,000 352,036,000 346,538,000 370,891,000 320,543,000 343,000,000 375,272,000 401,674,000 436,085,000 460,654,000 492,338,000 516,339,000 734,293 1,451,284 
        property and equipment
      		6,381,000 6,868,000 7,346,000 7,786,000 7,539,000 8,102,000 8,590,000 9,095,000 9,522,000 9,908,000 10,261,000 10,881,000 11,106,000 10,884,000 11,296,000 8,359,000 6,538,000 4,832,000 4,706,000   
        operating lease right-of-use assets
      		34,652,000 35,624,000 36,582,000 37,555,000 39,697,000 39,476,000 40,430,000 41,371,000 42,086,000 43,508,000 44,422,000 45,325,000 46,225,000 46,886,000 47,757,000 520,000 894,000 1,254,000 6,732,000   
        restricted cash, net of current portion
      		2,139,000 2,139,000 2,139,000 2,139,000 2,139,000 2,567,000 2,567,000 2,567,000 2,567,000 2,567,000 2,567,000 2,567,000 3,423,000 3,423,000 3,423,000 3,423,000 3,423,000 1,712,000    
        other assets
      		293,000 303,000 290,000 310,000 1,000 4,000 13,000 10,000 11,000 46,000 48,000 12,000 19,000 5,000 6,000 12,000 16,000 19,000 81,000   
        total assets
      		435,792,000 398,690,000 210,136,000 237,890,000 274,306,000 316,492,000 352,415,000 381,453,000 406,222,000 402,567,000 428,189,000 379,328,000 403,773,000 436,470,000 464,156,000 448,399,000 471,525,000 500,155,000 530,137,000 167,549,316 168,260,672 
        liabilities and stockholders' equity
      		                     
        current liabilities:
      		                     
        accounts payable
      		2,430,000 1,182,000 2,229,000 2,607,000 3,239,000 1,601,000 4,112,000 1,062,000 3,898,000 2,785,000 2,837,000 4,793,000 6,296,000 4,453,000 6,314,000 1,693,000 3,367,000 3,226,000 3,109,000 26,279 68,322 
        accrued expenses and other current liabilities
      		9,068,000 17,759,000 13,113,000 11,510,000 10,374,000 16,497,000 15,006,000 16,774,000 13,755,000 15,401,000 11,467,000 13,185,000 10,692,000 17,495,000 15,752,000 14,161,000 9,693,000 9,887,000 9,978,000   
        operating lease liabilities
      		2,832,000 2,738,000 3,102,000 2,534,000 2,824,000 2,454,000 2,863,000 2,364,000 2,066,000 2,082,000 2,040,000 1,807,000 2,638,000 1,770,000 781,000 629,000 1,075,000 1,503,000 1,092,000   
        total current liabilities
      		14,330,000 21,679,000 18,444,000 40,025,000 35,917,000 38,170,000 37,583,000 43,868,000 42,789,000 45,938,000 43,416,000 53,633,000 53,672,000 55,545,000 51,322,000 44,684,000 39,211,000 40,690,000 41,986,000 355,208 301,964 
        operating lease liabilities, net of current portion
      		29,956,000 30,832,000 31,661,000 32,474,000 34,122,000 34,039,000 34,763,000 35,473,000 36,169,000 36,838,000 37,466,000 38,082,000 38,735,000 39,361,000 39,947,000    6,089,000   
        total liabilities
      		44,286,000 52,511,000 50,105,000 102,936,000 107,550,000 116,975,000 123,245,000 133,780,000 141,770,000 149,459,000 151,594,000 166,383,000 176,509,000 186,994,000 191,084,000 149,695,000 151,169,000 155,408,000 164,724,000 6,191,458 6,138,214 
        commitments and contingencies
      		                     
        preferred stock, 0.001 par value...
      		                     
        stockholders' equity:
      		                     
        common stock, 0.001 par value...
      		144,000 136,000 112,000 111,000 108,000 108,000 107,000 107,000 107,000 102,000 102,000 88,000 88,000 88,000 88,000 88,000 88,000 88,000 88,000   
        additional paid-in capital
      		1,040,143,000 948,971,000 724,201,000 715,036,000 707,888,000 700,631,000 692,201,000 682,621,000 673,772,000 624,076,000 617,667,000 532,604,000 526,897,000 522,605,000 518,292,000 514,365,000 510,222,000 506,760,000 504,625,000 6,126,835 5,362,242 
        accumulated other comprehensive income
      		-115,000 224,000 121,000 94,000 194,000 336,000 750,000 -334,000 -257,000 186,000        -765,000 -10,000   
        accumulated deficit
      		-648,666,000 -603,152,000 -564,403,000 -580,287,000 -541,434,000 -501,558,000 -463,888,000 -434,721,000 -409,170,000 -371,256,000 -340,493,000 -318,230,000 -297,520,000 -269,512,000 -240,452,000 -211,402,000 -186,544,000 -161,336,000 -139,290,000 -1,127,401 -362,800 
        total stockholders’ equity
      		391,506,000 346,179,000 160,031,000 134,954,000 166,756,000 199,517,000 229,170,000 247,673,000 264,452,000 253,108,000 276,595,000 212,945,000 227,264,000 249,476,000 273,072,000 298,704,000 320,356,000 344,747,000 365,413,000 5,000,008 5,000,008 
        total liabilities and stockholders’ equity
      		435,792,000 398,690,000 210,136,000 237,890,000 274,306,000 316,492,000 352,415,000 381,453,000 406,222,000 402,567,000 428,189,000 379,328,000 403,773,000 436,470,000 464,156,000 448,399,000 471,525,000 500,155,000 530,137,000 167,549,316 168,260,672 
        deferred revenue
      		   23,374,000 19,480,000 17,618,000 15,602,000 23,668,000 23,070,000 25,670,000 27,072,000 33,848,000 34,011,000 31,792,000 28,475,000 28,200,000 25,024,000 26,022,000 27,807,000   
        deferred revenue, net of current portion
      		   30,437,000 37,511,000 44,766,000 50,899,000 54,439,000 62,812,000 66,683,000 70,712,000 74,668,000 84,102,000 92,088,000 99,815,000 105,011,000 111,958,000 114,718,000 116,649,000   
        accounts receivable
      		             2,000,000 2,000,000 2,000,000 2,000,000 2,000,000 8,000,000   
        income tax payable
      		            35,000 35,000  1,000 52,000 52,000    
        accumulated other comprehensive loss
      		          -681,000 -1,517,000 -2,201,000 -3,705,000 -4,856,000 -4,347,000 -3,410,000     
        other long-term liabilities
      		                     
        liabilities and stockholders’ equity
      		                     
        stockholders’ equity:
      		                     
        assets:
      		                     
        cash
      		                   582,938 1,258,456 
        prepaid expenses
      		                   151,355 192,828 
        investments held in trust account
      		                   166,815,023 166,809,388 
        liabilities and stockholders’ equity:
      		                     
        accrued expenses
      		                   292,811 202,089 
        accrued income taxes
      		                   526 7,389 
        franchise tax payable
      		                   35,592 24,164 
        deferred underwriting commissions
      		                   5,836,250 5,836,250 
        common stock; 15,635,785 and 15,736,221 shares subject to possible redemption at 10.00 per share as of june 30, 2021 and december 31, 2020, respectively
      		                   156,357,850  
        preferred stock, 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of june 30, 2021 and december 31, 2020, respectively
      		                     
        common stock, 0.0001 par value...
      		                   574 566 
        common stock; 15,712,245 and 15,736,221 shares subject to possible redemption at 10.00 per share as of march 31, 2021 and december 31, 2020, respectively
      		                    157,122,450 
        preferred stock, 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
      		                     
        1
      		                     
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
                           
          cash flows from operating activities
        		                   
          net loss
        		-45,514,000 -38,749,000 15,884,000 -38,853,000 -39,876,000 -37,670,000 -29,167,000 -25,551,000 -37,914,000 -30,763,000 -22,263,000 -20,710,000 -28,008,000 -29,060,000 -29,050,000 -24,858,000 -25,208,000 -22,046,000  
          adjustments to reconcile net loss to net cash from operating activities:
        		                   
          depreciation
        		463,000 479,000 555,000 625,000 622,000 620,000 622,000 632,000 625,000 617,000 613,000 604,000 581,000 570,000 417,000 312,000 309,000 256,000  
          noncash operating lease expense
        		972,000 958,000 973,000 1,018,000 1,012,000 954,000 941,000 925,000 925,000 914,000 911,000 904,000 877,000 882,000 803,000 374,000 361,000 321,000  
          stock-based compensation
        		10,797,000 5,980,000 6,625,000 6,570,000 7,255,000 7,462,000 7,178,000 7,538,000 6,719,000 4,879,000 4,860,000 5,121,000 4,219,000 3,785,000 3,815,000 3,425,000 3,205,000 2,257,000  
          accretion on marketable securities
        		-1,124,000 -768,000 -560,000 -722,000 -638,000 -856,000 -1,186,000 -1,204,000 -1,371,000           
          other
        		21,000 -19,000 -1,000 -1,000 -56,000 -10,000 0 43,000 -10,000 0   -889,000 -465,000 -219,000 -39,000 54,000 83,000  
          changes in operating assets and liabilities:
        		                   
          prepaid expenses and other current assets
        		-2,299,000 350,000 -1,652,000 -1,110,000 649,000 -889,000 -1,239,000 2,138,000 360,000 1,357,000 -1,120,000 321,000 -2,783,000 -757,000 11,347,000 -8,959,000 -3,687,000 63,000  
          other long-term assets
        		10,000 -13,000 20,000 -307,000 1,000 9,000 -2,000 1,000 35,000 1,000 -35,000 6,000 -13,000 59,000 55,000 4,000 4,000 -157,000  
          accounts payable
        		1,785,000 -1,231,000 -344,000 -880,000 1,630,000 -2,507,000 3,047,000 -2,766,000 1,042,000 -88,000 -1,957,000 -1,212,000 1,552,000 -1,040,000 4,493,000 -1,997,000 -359,000 365,000  
          accrued expenses and other liabilities
        		-8,690,000 4,488,000 1,604,000 1,136,000 -6,124,000 1,491,000 -1,768,000 3,020,000 -1,609,000 3,997,000 -1,781,000 2,458,000 -6,703,000 1,780,000 1,589,000 4,417,000 -157,000 35,000  
          operating lease liabilities
        		-781,000 -1,193,000 -245,000 -814,000 -780,000 -1,134,000 -210,000 -608,000 -188,000 -586,000 -392,000 -1,487,000 26,000 391,000 2,184,000 -446,000 -429,000 -363,000  
          deferred revenue
        		 0 -53,811,000 -3,181,000 -5,392,000 -4,117,000 -11,606,000 -7,775,000 -6,471,000 -5,431,000 -10,732,000 -9,598,000 -5,766,000 -4,411,000 -4,920,000 -3,771,000 -3,758,000 -3,716,000  
          net cash from operating activities
        		-44,360,000 -29,718,000 -30,952,000 -36,519,000 -41,697,000 -36,647,000 -33,390,000 -23,607,000 -37,857,000 -27,467,000 -31,135,000 -24,473,000 -34,907,000 -28,266,000 -19,611,000 -31,538,000 -29,665,000 -16,902,000 -41,861,340 
          capital expenditures
        		 -222,000 -185,000 -376,000 -43,000 -124,000 -115,000 -320,000 -124,000 0 -16,000 -664,000 -330,000 -1,862,000 -3,150,000 -1,488,000 -1,061,000 -959,000 0 
          free cash flows
        		 -29,940,000 -31,137,000 -36,895,000 -41,740,000 -36,771,000 -33,505,000 -23,927,000 -37,981,000 -27,467,000 -31,151,000 -25,137,000 -35,237,000 -30,128,000 -22,761,000 -33,026,000 -30,726,000 -17,861,000 -41,861,340 
          cash flows from investing activities
        		                   
          purchase of property and equipment
        		2,000 -222,000 -151,000 -624,000 -51,000 -124,000 -115,000 -320,000 -195,000     -1,041,000 -3,279,000 -1,811,000 -1,561,000 -696,000  
          sales and maturities of marketable securities
        		64,045,000 39,525,000 65,965,000 41,338,000 77,812,000 84,733,000 72,150,000 61,630,000 109,255,000 85,103,000 99,590,000 84,128,000 84,705,000 81,993,000 62,962,000 53,225,000 44,415,000 59,874,000  
          purchases of marketable securities
        		-54,412,000 -175,020,000 -18,337,000 -23,936,000 -47,164,000 -32,549,000 -39,465,000 -48,611,000 -120,263,000 -51,025,000 -156,238,000 -50,777,000 -52,534,000 -93,557,000 -44,455,000 -15,921,000 -54,571,000 -104,385,000  
          net cash from investing activities
        		9,635,000 -135,717,000 47,477,000 16,778,000 30,597,000 52,060,000 32,570,000 12,699,000 -11,203,000 33,852,000 -56,664,000 32,687,000 31,551,000 -12,605,000 15,228,000 35,493,000 -11,717,000 -45,207,000 -138,259,513 
          cash flows from financing activities
        		                   
          proceeds from at-the-market offerings, net of issuance costs
        		62,778,000      0 0 41,723,000           
          payment of transaction costs
        		-537,000                   
          proceeds from issuance of common stock under stock plans
        		17,605,000                   
          net cash from financing activities
        		79,846,000 219,376,000 2,541,000 581,000 2,000 969,000 2,402,000 1,311,000 42,982,000 1,467,000 80,280,000 586,000 73,000 527,000 113,000 718,000 257,000 -120,000  
          net change in cash, cash equivalents and restricted cash
        		45,121,000 53,941,000 19,066,000 -19,160,000 -11,098,000 16,382,000 1,582,000 -9,597,000 -6,078,000 7,852,000 -7,519,000 8,800,000 -3,283,000 -40,344,000 -4,270,000 4,673,000 -41,125,000 -62,229,000  
          cash, cash equivalents and restricted cash, beginning of period
        		114,846,000 0 0 0 72,097,000 0 0 0 69,808,000 0 0 0 63,958,000 0 0 0 145,024,000 0  
          cash, cash equivalents and restricted cash, end of period
        		159,967,000 53,941,000 19,066,000 -19,160,000 60,999,000 16,382,000 1,582,000 -9,597,000 63,730,000 7,852,000 -7,519,000 8,800,000 60,675,000 -40,344,000 -4,270,000 4,673,000 103,899,000 -62,229,000  
          supplemental cash flow information:
        		                   
          cash paid for leases
        		1,448,000 1,462,000 468,000 1,993,000 1,935,000 1,872,000 1,417,000 963,000 1,351,000 1,766,000 1,134,000 2,236,000 746,000  479,000 469,000 465,000 463,000  
          supplemental disclosure of noncash investing and financing activity:
        		                   
          purchases of property and equipment included in accounts payable and accrued expenses
        		  -34,000 248,000 8,000    71,000    290,000 -821,000 129,000 323,000 500,000 -263,000  
          operating lease liabilities from obtaining right-of-use assets
        		 0 0 0 1,308,000 0 0             
          revaluation of right-of-use asset and lease liability upon lease remeasurement
        		 0 0 1,124,000 75,000 0 0 0 497,000 0 -8,000 -5,000 -215,000       
          accounts receivable
        		         0 0 0 2,000,000       
          proceeds from issuance of common stock and pre-funded warrants
        		                   
          proceeds from issuance of common stock upon exercise of stock options and purchase of shares under espp
        		 7,012,000 2,541,000 581,000 2,000 969,000 2,402,000 1,311,000 1,259,000 841,000 441,000   527,000 113,000     
          return of capital from a stockholder - related party
        		                   
          right-of-use asset
        		             0      
          proceeds from issuance of common stock and pre-funded warrants, net of issuance costs
        		                   
          financing offering costs included in accounts payable and accrued expenses
        		                   
          capital expenditures included in accounts payable and accrued expenses
        		                   
          proceeds from issuance of common shares and pre-funded warrants
        		                   
          amortization on marketable securities
        		          739,000         
          purchases of property and equipment
        		          -16,000 -664,000 -620,000       
          payments of transaction costs
        		                   
          payment of business combination and pipe financing transaction costs
        		             0 0 0 -8,000 -221,000  
          proceeds from issuance of common stock upon exercise of stock options
        		            73,000    265,000 101,000  
          proceeds from issuance of preferred stock, net of issuance costs
        		                 0  
          business combination and pipe financing, gross proceeds
        		                 0  
          conversion of preferred shares to common shares
        		                 0  
          revaluation of right-of-use asset and lease liability upon lease modification
        		                   
          right-of-use asset obtained in exchange for a lease liability
        		                   
          remeasurement of right-of-use asset and lease liabilities due to lease modification
        		                   
          merger with bctg and pipe financing deferred offering costs included in accounts payable and accrued expenses
        		                   
          preferred stock issuance costs included in accounts payable and accrued expenses
        		                   
          cash flows from operating activities:
        		                   
          net income
        		                   
          interest earned on investments held in trust account
        		                   
          prepaid expenses
        		                   
          accrued expenses
        		                   
          accrued income taxes
        		                   
          franchise tax payable
        		                   
          cash flows from investing activities:
        		                   
          interest released from trust account
        		                   
          cash flows from financing activities:
        		                   
          proceeds from issuance of common stock to sponsor
        		                   
          proceeds from note payable to related party
        		                   
          net change in cash
        		                   
          cash - beginning of the period
        		                   
          cash - end of the period
        		                   
          supplemental disclosure of noncash activities:
        		                   
          deferred offering costs included in note payable - related party
        		                   
          deferred offering costs included in accrued expenses
        		                   
          change in value of common stock subject to possible redemption
        		                   
          ●